These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9696959)

  • 21. The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF Group.
    Ballesteros LC; Fernández San Martín MI; Sanz Cuesta T; Escortell Mayor E; López Bilbao C
    Pharmacoeconomics; 2001; 19(5 Pt 1):513-22. PubMed ID: 11465310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twelve-month drug cost savings related to use of an electronic prescribing system with integrated decision support in primary care.
    McMullin ST; Lonergan TP; Rynearson CS
    J Manag Care Pharm; 2005 May; 11(4):322-32. PubMed ID: 15871643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV
    J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in drug prescribing under the Public Health Reform Law--a survey of general practitioners' attitudes in East and West Germany.
    Himmel W; Kron M; Thies-Zajonc S; Kochen MM
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):164-9. PubMed ID: 9112138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower fragmentation of coordination in primary care is associated with lower prescribing drug costs-lessons from chronic illness care in Hungary.
    Lublóy Á; Keresztúri JL; Benedek G
    Eur J Public Health; 2017 Oct; 27(5):826-829. PubMed ID: 28957481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
    Fritze J
    Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
    Fritze J
    Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of prescription charges on repeat prescribing in primary care.
    Bradley F; Elvey R; Ashcroft DM; Noyce P
    J Clin Pharm Ther; 2007 Jun; 32(3):269-75. PubMed ID: 17489879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the effect of new hospital specialties on GP prescription costs.
    Simoens S; Gordon C; Scott A
    Health Policy; 2000 Jul; 52(3):171-8. PubMed ID: 10862992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auditing GPs' prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists.
    de Vries CS; van Diepen NM; Tromp TF; de Jong-van den Berg LT
    Eur J Clin Pharmacol; 1996; 50(5):349-52. PubMed ID: 8839654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of "group detailing" on drug prescribing in primary care.
    Mastura I; Teng CL
    Med J Malaysia; 2008 Oct; 63(4):315-8. PubMed ID: 19385492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription prices under the New York generic substitution law.
    Francetić I; Lasagna L; Weintraub M; Karch FE
    Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Referrals from general practice to consultants in Germany: if the GP is the initiator, patients' experiences are more positive.
    Rosemann T; Wensing M; Rueter G; Szecsenyi J
    BMC Health Serv Res; 2006 Jan; 6():5. PubMed ID: 16423299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Children referred for specialist care: a nationwide study in Dutch general practice.
    van Suijlekom-Smit LW; Bruijnzeels MA; van der Wouden JC; van der Velden J; Visser HK; Dokter HJ
    Br J Gen Pract; 1997 Jan; 47(414):19-23. PubMed ID: 9115787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UK interventions to control medicines wastage: a critical review.
    White KG
    Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
    Carroll NV; Rupp MT; Holdford DA
    J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis.
    de Bakker DH; Coffie DS; Heerdink ER; van Dijk L; Groenewegen PP
    BMC Health Serv Res; 2007 Aug; 7():132. PubMed ID: 17711593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact on drug costs and utilization of a clinical pharmacist in a multisite primary care medical group.
    Walker S; Willey CW
    J Manag Care Pharm; 2004; 10(4):345-54. PubMed ID: 15298532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.